Rezolute, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document And Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

SUBSEQUENT EVENTS (Details)

v3.22.4

SUBSEQUENT EVENTS (Details) - USD ($) $ in Millions			1 Months Ended
SUBSEQUENT EVENTS (Details) - USD ($) $ in Millions	Feb. 06, 2023	Jan. 08, 2023	Dec. 31, 2020
ActiveSite Pharmaceuticals, Inc \| Development And License Agreement [Member]
Subsequent Event [Line Items]
Milestone closing payment			$ 1.0
Subsequent Event \| ActiveSite Pharmaceuticals, Inc \| Phase 2 Clinical Trial RZ402 \| Development And License Agreement [Member]
Subsequent Event [Line Items]
Milestone closing payment	$ 3.0
Subsequent Event \| Executive Officers \| Minimum \| Termination Outside of Change in Control Event
Subsequent Event [Line Items]
Vesting period		12 months
Option exercisable Term		6 months
Subsequent Event \| Executive Officers \| Minimum \| Termination Due to Change in Control Event
Subsequent Event [Line Items]
Option exercisable Term		6 months
Subsequent Event \| Executive Officers \| Maximum \| Termination Outside of Change in Control Event
Subsequent Event [Line Items]
Vesting period		18 months
Option exercisable Term		12 months
Subsequent Event \| Executive Officers \| Maximum \| Termination Due to Change in Control Event
Subsequent Event [Line Items]
Option exercisable Term		12 months
Subsequent Event \| Chief Medical Officer \| Termination Outside of Change in Control Event
Subsequent Event [Line Items]
Vesting period		12 months
Option exercisable Term		6 months
Severance benefit equivalent to salary period		12 months
Insurance coverage period		12 months
Subsequent Event \| Chief Medical Officer \| Termination Due to Change in Control Event
Subsequent Event [Line Items]
Severance benefit equivalent to salary period		18 months
Insurance coverage period		18 months

- Definition

Amount of milestone payment made during the period.

+ References

No definition available.

+ Details

Name:	rzlt_MilestoneClosingPayment
Namespace Prefix:	rzlt_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Exercisable term of options in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	rzlt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableTerm
Namespace Prefix:	rzlt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The period of health insurance coverage under post employment benefits.

+ References

No definition available.

+ Details

Name:	rzlt_SupplementalUnemploymentBenefitsHealthInsuranceCoveragePeriod
Namespace Prefix:	rzlt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The period of salary equivalent which is provided as severance benefits.

+ References

No definition available.

+ Details

Name:	rzlt_SupplementalUnemploymentBenefitsSeveranceBenefitEquivalentToSalaryPeriod
Namespace Prefix:	rzlt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=rzlt_ActivesitePharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=rzlt_DevelopmentAndLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=rzlt_Phase2ClinicalTrialRz402Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=rzlt_TerminationOutsideOfChangeInControlEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=rzlt_TerminationDueToChangeInControlEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=rzlt_ChiefMedicalOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: